Citations (85)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Maliha Edgren, Jan-Erik Westlin, Henry Letocha, Hans Nordgren, Karl-Mikael Kälkner & Sten Nilsson. (1996) Estramustine-Binding Protein (EMBP) in Renal Cell Carcinoma Immunohistochemistry, Immunoscintigraphy and in Vitro Estramustine Effects. Acta Oncologica 35:4, pages 483-488.
Read now
Read now
S. Nilsson, H. Nordgren, S. Eklöv & M. Lögdahl. (1991) Expression of Ki-67—–A Proliferation-Associated Antigen—in Prostatic Cancer. Acta Oncologica 30:2, pages 177-179.
Read now
Read now
J.-G. Lehoux, B. Benard & M. Elhilali. (1980) Dihydrotestosterone Receptors in the Human Prostate. I. Nuclear Concentration in Normal, Benign, and Malignant Tissues. Archives of Andrology 5:3, pages 237-248.
Read now
Read now
Gösta Jönsson, Bertil Högberg & Torgny Nilsson. (1977) Treatment of Advanced Prostatic Carcinoma with Estramustine Phosphate (Estracyt®). Scandinavian Journal of Urology and Nephrology 11:3, pages 231-238.
Read now
Read now
Per Aage Høisaeter. (1977) In Vitro Binding of Tritiated Hormone-Cytostatic Complexes in the Cytosol of Various Rat Tissues and the Incorporation of These Complexes Into Nuclei. Scandinavian Journal of Urology and Nephrology 11:2, pages 135-141.
Read now
Read now
Torgny Nilsson & Jonas Müntzing. (1975) The Prognostic Value of Acid Phosphatase and β-Glucuronidase Activity in Biopsy Specimens from Patients with Reactivated Prostatic Cancer. Scandinavian Journal of Urology and Nephrology 9:3, pages 205-207.
Read now
Read now
K. Sjövall, S. Rubin & J. Müntzing. (1975) Creatine Phosphokinase in Prostatic Tissue. Scandinavian Journal of Urology and Nephrology 9:3, pages 181-184.
Read now
Read now
J. Müntzirig, T. Nilsson & J. Polacek. (1974) Zinc and β-Glucuronidase in the Human Prostate. Scandinavian Journal of Urology and Nephrology 8:2, pages 87-90.
Read now
Read now
Torgny Nilsson & Jonas Müntzing. (1973) Histochemical and Biochemical Investigation of Advanced Prostatic Carcinoma Treated with Estramustine Phosphate, Estracyt. Scandinavian Journal of Urology and Nephrology 7:1, pages 18-22.
Read now
Read now
Torgny Nilsson & Jonas Müntzing. (1972) Estracyt® in Advanced Prostatic Carcinoma: Case Report. Scandinavian Journal of Urology and Nephrology 6:1, pages 11-16.
Read now
Read now
Articles from other publishers (75)
Gaetano Aurilio, Rossella Graffeo, Vincenzo Bagnardi, Franco Nolè, Laura Adamoli, Olivia Pagani, Elisa Gallerani, Benvenuto Ferrari, Giancarlo Pruneri & Aron Goldhirsch. (2014) Estramustine phosphate sodium in heavily pretreated patients with metastatic breast cancer: a retrospective consecutive case series. International Journal of Clinical Oncology 20:1, pages 90-94.
Crossref
Crossref
Gary HudesNaomi HaasGwen YeslowThomas GillonPer Olov GunnarssonMarianne EllmanOrjan NordleBrigitta ErikssonLangdon MillerLaura CisarMichael KopreskiDonatella ViaroBeryl Hartley-Asp. (2002) Phase I Clinical and Pharmacologic Trial of Intravenous Estramustine Phosphate. Journal of Clinical Oncology 20:4, pages 1115-1127.
Crossref
Crossref
Hiroaki Shiina, Mikio Igawa, Kazushi Shigeno, Yakihiro Wada, Tatsuaki Yoneda, Hiroki Shirakawa, Tomoyuki Ishibe, Ritsuko Shirakawa, Makoto Nagasaki, Takeshi Shirane & Tsuguru Usui. (1997) Immunohistochemical analysis of estramustine binding protein with particular reference to proliferative activity in human prostatic carcinoma. The Prostate 32:1, pages 49-58.
Crossref
Crossref
Willi Kreis. 1995. Concepts, Mechanisms, and New Targets for Chemotherapy. Concepts, Mechanisms, and New Targets for Chemotherapy
163
184
.
Tsutomu Nishiyama & Masahiro Terunuma. (2007) PROSTATE SPECIFIC ANTIGEN AND PROSTATE ACID PHOSPHATASE DECLINES AFTER ESTRAMUSTINE PHOSPHATE WITHDRAWAL: A CASE REPORT. International Journal of Urology 1:4, pages 355-356.
Crossref
Crossref
Peter Ekman. 1991. The Medical Management of Prostate Cancer II. The Medical Management of Prostate Cancer II
45
52
.
C.L. Eaton & K. Griffiths. (1990) 5 The role of endocrine therapy in prostatic cancer. Baillière's Clinical Endocrinology and Metabolism 4:1, pages 85-96.
Crossref
Crossref
Fuad S. Freiha, Malcolm A. Bagshaw & Frank M. Torti. (1988) Carcinoma of the prostate: pathology, staging, and treatment. Current Problems in Cancer 12:6, pages 331-397.
Crossref
Crossref
Iwao Nishiya, Noboru Yoshizumi, Masayuki Sato, Teruo Kagabu, Jun Fujiwara & Akira Yoshizaki. (2010) Flow Cytometric Study of Site‐Directed Chemotherapy with Estradiol‐17β as a Drug Carrier to Human Endometrial Adenocarcinoma Cells in vitro. Asia-Oceania Journal of Obstetrics and Gynaecology 13:3, pages 359-368.
Crossref
Crossref
Åke Pousette, Per Björk & Kjell Carlström. (1987) Hormonal regulation of an estramustine-binding protein in the submaxillary gland of the rat. Journal of Steroid Biochemistry 26:1, pages 31-34.
Crossref
Crossref
K. Pavelić, I. Zgradić, M. Osmak & M. Popović. (1985) Estramustine phosphate-reduced proliferation of murine and human cell lines and murine transplantable tumors. Research in Experimental Medicine 185:3, pages 233-243.
Crossref
Crossref
Arnold Mittelman. (1984) Effect of previous treatment on Estracyt response in advanced Stage D prostatic carcinoma. Urology 23:6, pages 78-80.
Crossref
Crossref
Nelson H. Slack & Gerald P. Murphy. (1984) Clinical toxicity and long-term results of Emcyt therapy for prostate cancer. Urology 23:6, pages 73-77.
Crossref
Crossref
Ralph C. BensonJr.Jr.. (1984) Estramustine phosphate as primary therapy for metastatic prostate cancer. Urology 23:6, pages 69-72.
Crossref
Crossref
Gerald P. Murphy, Nelson H. Slack & Arnold Mittelman. (1984) Use of estramustine phosphate in prostate cancer by the National Prostatic Cancer Project and by Roswell Park Memorial Institute. Urology 23:6, pages 54-63.
Crossref
Crossref
Torgny Nilsson & Jonas Müntzing. (1984) Initial clinical studies with estramustine phosphate. Urology 23:6, pages 49-50.
Crossref
Crossref
Terje Kalland & Svein A. Haukaas. (1984) Immunologic effects of estramustine phosphate. Urology 23:6, pages 39-45.
Crossref
Crossref
Per Olov Gunnarsson & Gustaf Plym Forshell. (1984) Clinical pharmacokinetics of estramustine phosphate. Urology 23:6, pages 22-27.
Crossref
Crossref
Jean B. deKernion & Arie Lindner. (1984) Chemotherapy of Hormonally Unresponsive Prostatic Carcinoma. Urologic Clinics of North America 11:2, pages 319-326.
Crossref
Crossref
P. O. Gunnarsson, S. -B. Andersson, S. -�. Johansson, T. Nilsson & G. Plym-Forshell. (1984) Pharmacokinetics of estramustine phosphate (Estracyt�) in prostatic cancer patients. European Journal of Clinical Pharmacology 26:1, pages 113-119.
Crossref
Crossref
A. Basso. 1984. Geriatrics 3. Geriatrics 3
193
212
.
L. R. Murthy, C. H. Chang, D. R. Rowley, P. T. Scardino & D. J. Tindall. (2006) Physicochemical characterization of the androgen receptor from hyperplastic human prostate. The Prostate 5:6, pages 567-579.
Crossref
Crossref
Oscar Hechter. (2007) Susceptibility of the prostate cancer cell to different physical, hormonal, and chemical agents: Present status and theoretical prospects for improved prostate cancer therapy. The Prostate 5:2, pages 159-180.
Crossref
Crossref
Per Olov Gunnarsson, Sven-Börje Andersson & Sven-Åke Johansson. (1983) The hydrolysis of estramustine phosphate; in vitro studies. European Journal of Drug Metabolism and Pharmacokinetics 8:4, pages 395-402.
Crossref
Crossref
D. DAPONTE, R. SYLVESTER, M. DE PAUW, A. FRYSZMAN, R. M. SMITH & P. H. SMITH. (2008) Change in White Cell Count during Treatment of Advanced Cancer of the Prostate with Estramustine Phosphate and with Stilboestrol. British Journal of Urology 55:4, pages 408-412.
Crossref
Crossref
G. D. Chisholm & L. L. Beynon. 1982. The Endocrinology of Prostate Tumours. The Endocrinology of Prostate Tumours
241
262
.
N.H. Slack, M.F. Brady & Gerald P. Murphy. (1982) Observations of prolonged use of oral emcyt in prostatic cancer patients. Urology 20:5, pages 515-523.
Crossref
Crossref
Svein A. Haukaas & Terje Kalland. (1982) Effects of Diethylstilbestrol and Estramustine Phosphate (Estracyt) on Lymphoid Cell Populations and Mitogen Responsiveness in Male Mice. Journal of Urology 128:4, pages 862-868.
Crossref
Crossref
J.E. Dinchuk, L.S. Chai, J.P. Karr, G.P. Murphy & A.A. Sandberg. (1982) Effects of estramustine and megestrol on ultrastructure of rat ventral prostate. Urology 19:5, pages 511-522.
Crossref
Crossref
F. Zattoni, A. Lembo, P. Graziotti, G. Artuso, A. RebuffiG. Costantin. (2019) Le Modificazioni Citologiche Indotte Dal Trattamento Del Cancro Prostatico. Urologia Journal 49:2, pages 243-246.
Crossref
Crossref
F. M. Torti & S. K. Carter. 1982. Chemotherapy and Urological Malignancy. Chemotherapy and Urological Malignancy
80
96
.
Svein Haukaas, Per Åge Høisaeter & Terje Kalland. (2006) In vitro and in vivo effects of diethylstilbestrol and estramustine phosphate (estracyt®) on the mitogen responsiveness of human peripheral blood lymphocytes. The Prostate 3:4, pages 405-414.
Crossref
Crossref
S. B. Andersson, P. O. Gunnarsson, T. Nilsson & G. Plym Forshell. (1981) Metabolism of estramustine phosphate (Estracyt ®) in patients with prostatic carcinoma. European Journal of Drug Metabolism and Pharmacokinetics 6:2, pages 149-154.
Crossref
Crossref
ÅKe Pousette, Per Björk, Kjell Carlström, Björn Forsgren, Bertil Högberg & Jan‐Åke Gustafsson. (2006) Influence of prostatic secretion protein on uptake of androgen‐receptor complex in prostatic cell nuclei. The Prostate 2:1, pages 23-33.
Crossref
Crossref
Marvin A. Brooks & Ross Dixon. (1980) Determination of estramustine and its 17-keto metabolite in plasma by high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications 182:3, pages 387-394.
Crossref
Crossref
Joseph D. Schmidt. (1980) Chemotherapy of Hormone-Resistant Stage D Prostatic Cancer. Journal of Urology 123:6, pages 797-805.
Crossref
Crossref
E.K. Muechler & D. Kohler. (1979) Interaction of the cytotoxic agent estramustine phosphate (Estracyt) with the estrogen receptor of the human uterus. Gynecologic Oncology 8:3, pages 330-338.
Crossref
Crossref
Jonas Müntzing, Gunborg Jensen & Bertil Högberg. (2009) Pilot Study on the Growth Inhibition by Estramustine Phosphate (Estracyt®) of Rat Mammary Tumours Sensitive and Insensitive to Oestrogen. Acta Pharmacologica et Toxicologica 44:1, pages 1-6.
Crossref
Crossref
N. Christine Alexander, A. Kathleen Hancock, Muneera B. Masood, B. Gadsby Peet, J.J. Price, R.L. Turner, Joan Stone & A.J. Ward. (1979) Estracyt in advanced carcinoma of the breast: A phase II study. Clinical Radiology 30:2, pages 139-147.
Crossref
Crossref
Åke Pousette, Marek Snochowski, Dominique Bression, Bertil Högberg & Jan-Åke Gustafsson. (1979) Partial characterization of [3H]methyltrienolone binding in rat prostate cytosol. Biochimica et Biophysica Acta (BBA) - General Subjects 582:2, pages 358-367.
Crossref
Crossref
G. Martz. 1979. Internistische Krebstherapie. Internistische Krebstherapie
337
349
.
L.‐E. Appelgren, B. Forsgren, J.‐Å. Gustafsson, Å. Pousette & B. Högberg. (2009)
Autoradiographic Studies of
3
H‐estramustine in the Rat Ventral Prostate
. Acta Pharmacologica et Toxicologica 43:5, pages 368-374.
Crossref
Crossref
A. Piccinno, A. Guido, U. Di Rienzo, L. Bruno & E. Cirillo-Marucco. (2018) L'Estramustinfosfato Nel Trattamento Del Carcinoma Della Prostata Insensibile Agli Estrogeni. Urologia Journal 45:3, pages 236-240.
Crossref
Crossref
A. V. Bono. (2018) Protocollo Di Trattamento per Il Carcinoma Prostatico. Urologia Journal 44:6, pages 762-774.
Crossref
Crossref
G. D. CHISHOLM, E. P. N. O'DONOGUE & C. L. KENNEDY. (1977) The Treatment of Oestrogen-Escaped Carcionoma of the Prostate with Estramustine Phosphate. British Journal of Urology 49:7, pages 717-720.
Crossref
Crossref
S.D. Fosså, J. Fosså & A. Aakvaag. (1977) Hormone Changes in Patients with Prostatic Carcinoma, During Treatment with Estramustine Phosphate. Journal of Urology 118:6, pages 1013-1018.
Crossref
Crossref
Kenneth B. Cummings & R. Paul Robertson. (1977) Prostaglandin: Increased Production by Renal Cell Carcinoma. Journal of Urology 118:5, pages 720-723.
Crossref
Crossref
Jonas Muntzing, Rashad Y. Kirdani, Jack Saroff, Gerald P. Murphy & Avery A. Sandberg. (1977) Inhibitory effects of estracyt on R-3327 rat prostatic carcinoma. Urology 10:5, pages 439-445.
Crossref
Crossref
Daniel D. Von Hoff, Marcel Rozencweig, Milan Slavik & Franco M. Muggia. (1977) Estramustine Phosphate: A Specific Chemotherapeutic Agent?. Journal of Urology 117:4, pages 464-466.
Crossref
Crossref
R. NAGEL & C.-P. KÖLLN. (1977) Treatment of Advanced Carcinoma of the Prostate with Estramustine Phosphate. British Journal of Urology 49:1, pages 73-79.
Crossref
Crossref
Philip H. Smith, Melvyn R.G. Robinson & Edward H. Cooper. (1976) Carcinoma of the prostate: A focal point for divergent disciplines. European Journal of Cancer (1965) 12:12, pages 937-944.
Crossref
Crossref
Lowell E. Schnipper. (1976) The Role of Chemotherapy in the Management of Malignant Urogenital Neoplasms. Urologic Clinics of North America 3:2, pages 423-432.
Crossref
Crossref
A. Mittelman, S.K. Shukla & G.P. Murphy. (1976) Extended Therapy of Stage D Carcinoma of the Prostate with Oral Estramustine Phosphate. Journal of Urology 115:4, pages 409-412.
Crossref
Crossref
Sophie Dorothea Fosså & Ashton Miller. (1976) Treatment of Advanced Carcinoma of the Prostate with Estramustine Phosphate. Journal of Urology 115:4, pages 406-408.
Crossref
Crossref
Guy Leclercq, Jean-Claude Heuson & Marie-Christine Deboel. (1976) Estrogen receptors interaction with Estracyt and degradation products, a biochemical study on a potential agent in the treatment of breast cancer. European Journal of Drug Metabolism and Pharmacokinetics 1:2, pages 77-84.
Crossref
Crossref
Torgny Nilsson & Gosta Jonsson. (1976) Primary Treatment of Prostatic Carcinoma with Estramustine Phosphate: Preliminary Report. Journal of Urology 115:2, pages 168-169.
Crossref
Crossref
G.P. Murphy. 1976.
399
415
.
G. Jönsson, A.M. Olsson, W. Luttrop, Z. Cekan, K. Purvis & E. Diczfalusy. 1976.
351
376
.
J.G. Forsberg & P.A. Høisaeter. 1976.
137
154
.
K. W. Brunner & G. A. Nagel. 1976. Internistische Krebstherapie. Internistische Krebstherapie
292
303
.
Stephen K. Carter & Todd H. Wasserman. (1975) The chemotherapy of urologic cancer. Cancer 36:S2, pages 729-747.
Crossref
Crossref
A.A. Sandberg, H. Rosenthal, A. Mittelman & G.P. Murphy. (1975) Prostatic cancer Transcortin levels during treatment with estramustine phosphate. Urology 6:1, pages 17-21.
Crossref
Crossref
Torben B. Kjaer, Torgny Nilsson & Paul O. Madsen. (1975) Effect of estramustine phosphate on plasma testosterone during treatment of carcinoma of prostate. Urology 5:6, pages 802-804.
Crossref
Crossref
F. Balogh & L. Kisbenedek. (1975) Treatment of prostatic cancer with estracyt® (estramustine phosphate). International Urology and Nephrology 7:2, pages 135-140.
Crossref
Crossref
Joseph D. Schmidt. (1975) Chemotherapy of Prostatic Cancer. Urologic Clinics of North America 2:1, pages 185-196.
Crossref
Crossref
Martin I. Resnick & John T. Grayhack. (1975) Treatment of Stage IV Carcinoma of the Prostate. Urologic Clinics of North America 2:1, pages 141-161.
Crossref
Crossref
Z. Szenddrői, I. Könyves, L. Szendi, S. Eckhardt & F. Hartay. (1974) Estracyt in hormone-resistant prostatic carcinoma. International Urology and Nephrology 6:2, pages 101-110.
Crossref
Crossref
G. D. Chisholm. 1974. The Treatment of Prostatic Hypertrophy and Neoplasia. The Treatment of Prostatic Hypertrophy and Neoplasia
121
146
.
William W. Scott. (1973) Rationale and results of primary endocrine therapy in patients with prostatic cancer. Cancer 32:5, pages 1119-1125.
Crossref
Crossref
Gerald P. Murphy. (1973) Cancer of the prostate. Cancer 32:5, pages 1089-1091.
Crossref
Crossref
H.-K. BüscherC.-P. Kölln & R. Nagel. 1973. 24. Tagung vom 13. bis 16. September 1972 in Hannover. 24. Tagung vom 13. bis 16. September 1972 in Hannover
303
305
.
T. Nilsson & J. Müntzing. (2006) Some biochemical and histochemical aspects in hyperplasia and carcinoma of the human prostate. Journal of Surgical Oncology 5:3, pages 205-214.
Crossref
Crossref
Bengt Lindberg. (1972) Treatment of Rapidly Progressing Prostatic Carcinoma with Estracyt. Journal of Urology 108:2, pages 303-306.
Crossref
Crossref
J. M�ntzing & T. Nilsson. (1972) Lipofuscin in malignant and non-malignant human prostatic tissue. Zeitschrift f�r Krebsforschung und Klinische Onkologie 77:2, pages 166-170.
Crossref
Crossref
Maud Andersson & Jonas Müntzing. (2009) Effects of Oestrogen on Phosphatase Activity in the Ventral Prostate of Intact, Castrated, and Androgen-treated Castrated, Adult Rats. Acta Pharmacologica et Toxicologica 30:3-4, pages 193-202.
Crossref
Crossref